Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06578650 · ClinicalTrials.gov registry record
A Prospective, Single-arm, Clinical Trial of Electrospun Fiber Matrix (Restrata) in the Treatment of Surgical Defects Secondary to Resection of Malignant Cutaneous Neoplasms
A clinical trial of Surgical Wound, sponsored by Acera Surgical.
- Recruiting
- Registry status
- 34
- Enrollment target
- 1
- Study location
NCT06578650 is a study of Surgical Wound that is actively recruiting participants, run by Acera Surgical. The registered enrollment target is 34 participants, below the 93-participant average among 17 other Surgical Wound trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06578650, a study of Surgical Wound, is actively recruiting participants, sponsored by Acera Surgical.
- RECRUITING
- Registry status
- 34 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational prospective study is to evaluate wound healing outcomes in resection wounds resulting from surgical removal of cutaneous malignancies treated with a synthetic electrospun fiber matrix. This study intends to quantify the time from initial resection and product application to time of complete granulation of the wound bed in weeks.
Conditions Studied
Interventions
- DEVICE Synthetic Electrospun Fiber Matrix
Study Locations (1)
Nevada
- University Nevada - Las Vegas - Las Vegas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2024-10-31 |
| Est. Completion | 2027-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06578650
The ClinicalTrials.gov registry entry for NCT06578650 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 93-participant average among 17 other Surgical Wound trials with a reported enrollment target (63% lower). The listed sponsor is Acera Surgical, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Surgical Wound appearing as the primary indexed condition, and to 1 intervention - of which Synthetic Electrospun Fiber Matrix is the first listed.
NCT06578650 reports 1 study location spanning 1 distinct geographic area - top geographies include Nevada.
Frequently Asked Questions
What is clinical trial NCT06578650 about?
NCT06578650 is a clinical study titled "A Prospective, Single-arm, Clinical Trial of Electrospun Fiber Matrix (Restrata) in the Treatment of Surgical Defects Secondary to Resection of Malignant Cutaneous Neoplasms". The goal of this observational prospective study is to evaluate wound healing outcomes in resection wounds resulting from surgical removal of cutaneous malignancies treated with a synthetic electrospun fiber matrix. This study intends to quantify the time from initial resection and product applicati...
What is the current status of trial NCT06578650?
This trial is currently recruiting. The enrollment target is 34 participants. The study started on 2024-10-31. Estimated completion is 2027-05.
What conditions does trial NCT06578650 study?
This clinical trial studies the following conditions: Surgical Wound.
What interventions are being tested in trial NCT06578650?
The interventions under investigation include: Synthetic Electrospun Fiber Matrix (DEVICE).
Who is sponsoring clinical trial NCT06578650?
This trial is sponsored by Acera Surgical, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06578650 being conducted?
This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Surgical Wound
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Zinc Oxide Versus Petrolatum Following Skin Surgery
RECRUITING · Early Phase 1
-
Evaluating rhPDGF-BB-Enhanced Wound Matrix for Head and Neck Reconstruction
RECRUITING · Phase 2
-
Early Versus Delayed Bathing of Orthopaedic Surgical Wounds
RECRUITING · NA
-
fMRI and IVCM Cornea Microscopy of CXL in Keratoconus
RECRUITING
-
Regenn® Therapy System Safety Study
RECRUITING · Phase 1
-
Multicenter Single-arm Trial to Investigate Clinical Outcomes When Cohealyx™ is Used for Full Thickness Wounds
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.